By integrating multi-omics data from public repositories and applying machine learning-driven feature selection, we identified three core biomarkers—FABP4,CDR2L,and FSTL3 that independently predicted overall survival in CRC patients with diabetes. Here, CDR2L is linked to colorectal carcinoma.